Measuring Compression: The Outcomes Framework
AI investments fail to get organizational traction when they're measured in the wrong units. "Our team saves 10 hours a week" is hard to act on. "We can move IND submission six weeks earlier" is a decision.
The translation stack
There are four levels of measurement, and most organizations operate at the bottom two:
Level 1 — Activity: Tasks completed, prompts run, documents generated. This is operational data. It's useful for tracking adoption, not value.
Level 2 — Efficiency: Time saved per task, reduction in revision cycles, reduction in coordination overhead. This is where most AI measurement stops. It's necessary but insufficient.
Level 3 — Capacity: What does the recovered time enable? If regulatory writers save 20 hours per week, what do they do with those 20 hours? If the answer is "more of the same," you haven't changed your outcomes. If the answer is "we can now run two submissions simultaneously," you have.
Level 4 — Outcomes: Program timeline compression, IND/NDA acceleration, earlier patient access, capital efficiency (same output with fewer resources or faster burn-through). This is where the executive conversation happens.
The biotech outcome metrics that matter
For development-stage biotechs, the metrics that move valuations and investor confidence are:
- Months to next regulatory milestone (IND, Phase 2 start, NDA submission)
- Clinical trial enrollment rate (patients per site per month)
- Regulatory approval cycle time (submission to approval)
- R&D spend per program per year relative to stage progress
- Headcount efficiency (output per FTE as programs scale)
For each of these, identify which AI use cases in your leverage map have a credible line of impact. Document the causal chain: AI use case → time saved → capacity freed → specific milestone it enables → months accelerated.
The 90-day test
The most useful measurement approach is a 90-day sprint: identify the three highest-leverage use cases, implement them, and measure outcomes (not just efficiency) at day 90. A well-designed 90-day sprint typically shows one to two weeks of critical-path acceleration per month, which compounds across a program.
That's the conversation that gets budget, headcount, and executive sponsorship.